参考文献/References:
1 Klassen C D.Distribution,excretion and absorp-tion of toxicants,in Casarett and Doul’s Toxicol-ogy.The Basic Science of Poisons,3rd edn (eds C.D Klaassen,M.D.Amdur and J.Doul),Macmillan Publishing,New York,1986,33-63
2 Vallabhajosula S et al.J Nucl Med,1989;30:599～604
3 Weber DA et al J Nucl Med,1989;30:1117～22
4 Krishnamurthy GT and Turner FE.Semin Nucl Med,1990;22:130～149
5 Owunwanne A et al.The Handbook of Radio-pharmaceuticals,Published by Chapman & Hall,2-6 Boundary Row,London Sel 8HN,UK,1995
相似文献/References:
[1]李海峰,张晓军,张锦明.多巴胺转运蛋白显像剂11C-β-CFT在帕金森病中的应用研究[J].国际放射医学核医学杂志,2016,40(3):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
Li Haifeng,Zhang Xiaojun,Zhang Jinming.Review of the use of dopamine transporter imaging agent 11C-β-CFT for diagnosing Parkinson disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
[2]甘红梅,乔晋萍,孔爱英,等.正电子放射性显像剂代谢及其研究方法进展[J].国际放射医学核医学杂志,2010,34(2):65.[doi:10.3760/cma.j.issn.1673-4114.2010.02.001]
GAN Hong-mei,QIAO Jin-ping,KONG Ai-ying,et al.The progress on researching method and metabolism of positron radiopharmaceutical[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(4):65.[doi:10.3760/cma.j.issn.1673-4114.2010.02.001]
[3]顾涛颖,石洪成.放射性药物治疗肿瘤骨转移性骨痛的作用[J].国际放射医学核医学杂志,2010,34(2):88.[doi:10.3760/cma.j.issn.1673-4114.2010.02.006]
GU Tao-ying,SHI Hong-cheng.The use of radiopharmaceuticals for metastatic bone pain in cancer patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(4):88.[doi:10.3760/cma.j.issn.1673-4114.2010.02.006]
[4]周雪,乔晋萍,孔爱英,等.受体结合实验及其在放射性显像剂研究中的应用进展[J].国际放射医学核医学杂志,2010,34(6):321.[doi:10.3760/cma.j.issn.1673-4114,2010.06.001]
ZHOU Xue,QIAO Jin-ping,KONG Ai-ying,et al.Progress on the application of ligand receptor binding assays in radiopharmaceuticals[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(4):321.[doi:10.3760/cma.j.issn.1673-4114,2010.06.001]
[5]彭添兴,吴华.18F-氟脱氧葡萄糖以外新型PET肿瘤显像剂[J].国际放射医学核医学杂志,2007,31(1):9.
PENG Tian-xing,WU Hua.New type PET imaging agent excluding 18F-fluorodeoxyglucose in oncology[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(4):9.
[6]范我.用于肿瘤治疗的放射性药物[J].国际放射医学核医学杂志,2004,28(1):21.
FAN Wo.Radiopharmaceuticals for tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(4):21.
[7]陈璟,吴华.核素炎症显像的研究进展[J].国际放射医学核医学杂志,2003,27(3):107.
CHEN Jing,WU Hua.The development of radionuclide imaging of infection and inflammation[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(4):107.
[8]杨建权,李晔,张现忠.基于小分子肽的放射性药物[J].国际放射医学核医学杂志,2003,27(4):157.
YANG Jian-quan,LI Ye,ZHANG Xian-zhnng.Peptide as carrier for diagnosis and treatment[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(4):157.
[9]谷晓云.核医学诊断操作中的亚细胞水平吸收剂量及其生物效应[J].国际放射医学核医学杂志,2001,25(4):165.
GU Xiao-yun.Cellular dosimetry and biological conseuences caused by diagnostic nuclear medicine[J].International Journal of Radiation Medicine and Nuclear Medicine,2001,25(4):165.
[10]袁志斌.获得FDA批准的放射性药物[J].国际放射医学核医学杂志,2000,24(4):161.
YUAN Zhi-bin.FDA approved radiopharmaceuticals[J].International Journal of Radiation Medicine and Nuclear Medicine,2000,24(4):161.